← Eichor
Condition: Acth Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acth

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
Phase N/A · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06962202A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Phase 3 · 31 location(s) · Cerium Pharmaceuticals, Inc. · NCT05696613Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06635629Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Phase 2 · 1 location(s) · Rutgers, The State University of New Jersey · NCT05703425Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disea
Phase N/A · 1 location(s) · Mayo Clinic · NCT07335315Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT03374215Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitar
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07463625FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07460232Accelerated iTBS for Major Depression
NA · 1 location(s) · Istanbul University - Cerrahpasa · NCT07603804A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Crinetics Pharmaceuticals Inc. · NCT05804669Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Phase 2 · 1 location(s) · University of California, Los Angeles · NCT05971758Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospe
Phase 3 · 8 location(s) · Mao Jianhua · NCT06079788Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Phase 2 · 1 location(s) · Cedars-Sinai Medical Center · NCT03774446Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrom
Phase 2 · 15 location(s) · RECORDATI GROUP · NCT03708900Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
Phase N/A · 1 location(s) · Mayo Clinic · NCT04543253Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Phase 4 · 1 location(s) · Johns Hopkins University · NCT07247058DDAVP for Pituitary Adenoma
NA · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT04569591Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02019706An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00001595A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Phase 2 · 27 location(s) · H. Lundbeck A/S · NCT06471829Cerebrovascular Disease: Quality of Life (CODE: QoL)
Phase N/A · 1 location(s) · University of Zurich · NCT06443268Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Witho
Phase N/A · 1 location(s) · Qifu Li · NCT06955286Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
NA · 1 location(s) · Microgen LLC · NCT05012072Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · 60 location(s) · Sparrow Pharmaceuticals · NCT07296484Evaluation of the Effects of Laughter Yoga
NA · 1 location(s) · Firat University · NCT07524231IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT07361874Overnight Dexamethasone in Primary Aldosteronism Screening
Phase N/A · 1 location(s) · Medical University of Gdansk · NCT06740838Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07350707
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.